Skip to main content
. 2017 Jun 21;82(6):824–832. doi: 10.1093/neuros/nyx312

FIGURE 2.

FIGURE 2.

Subsequent recurrence and OS after first recurrence. A, Competing risks regression model for recurrence/progression after first recurrence. Death was considered a competing risk. Half the patients were likely to experience a second recurrence within 2 yr of being treated for a first recurrence. B, Kaplan–Meier estimates of OS after first recurrence. OS decreased from 5.2 yr after first recurrence to 3.7 yr after a second recurrence.